Latest News

Latest News

Neurodegeneration Pipeline 2026: Genetic Medicine Leads

Neurodegeneration Pipeline 2026: Genetic Medicine Leads

Last updated 5 November 2026. The FDA accepted uniQure’s Huntington’s gene therapy application for priority review, with a target action date of 1 May 2027. The neurodegeneration pipeline looks very different from the one that opened 2026. Two events in the first week...

read more
The Future of Collagen Hydrogels in Regenerative Medicine

The Future of Collagen Hydrogels in Regenerative Medicine

Collagen hydrogels are still the benchmark for regenerative medicine because they provide cells with an environment that feels biologically familiar. However, the next challenge within this field is no longer proving whether or not collagen works, but in capably...

read more

Join The Future Of Life Sciences Media

 

In a world overflowing with information, LifeScienceDaily.news stands apart as the dedicated space where life sciences professionals share what’s new, what’s next, and why it matters, all in real time.

 

 

Don’t wait for the media to pick up your story. Be the media.

More News

GSK Makes $2.2 Billion Bid for RAPT Therapeutics

GSK Makes $2.2 Billion Bid for RAPT Therapeutics

GSK has agreed to acquire US biotech company RAPT Therapeutics in a deal valued at approximately 2.2 billion US dollars, strengthening its position in immunology and signalling a major push into the emerging food allergy treatment market. The acquisition centres on...

read more
What is the Metabolic Reset Diet – The Science

What is the Metabolic Reset Diet – The Science

The science, the promise, and the pitfalls The idea of a “metabolic reset” has gained traction across wellness media, social platforms, and weight management programmes. The premise is appealing: that metabolism can be “retrained” or “rebooted” through short-term...

read more
Functional Gut Clinic Launches GI Clinical Trials Division

Functional Gut Clinic Launches GI Clinical Trials Division

The Functional Gut Clinic (FGC), the UK’s leading provider of specialist gastrointestinal (GI) diagnostics, today announced the launch of its dedicated GI Clinical Trials establishing the organisation as the country’s first boutique, end‑to‑end clinical research...

read more
Ergonomic Design Considerations in Health Tech

Ergonomic Design Considerations in Health Tech

Why comfort and fit are essential design considerations in medical devices In many industries, product design rarely accounts for the variability of user profiles, with a focus on the ‘average’ person.  Headphones or even glasses too often do not account for head size...

read more
EQT Targets Oxford Biomedica in Major Biotech Takeover Bid

EQT Targets Oxford Biomedica in Major Biotech Takeover Bid

Oxford Biomedica has officially confirmed it is in preliminary discussions with the Swedish private equity giant EQT regarding a potential cash takeover. The announcement follows significant market speculation and a sharp rise in the company’s share price on January...

read more
GSK Makes $2.2 Billion Bid for RAPT Therapeutics

GSK Makes $2.2 Billion Bid for RAPT Therapeutics

GSK has agreed to acquire US biotech company RAPT Therapeutics in a deal valued at approximately 2.2 billion US dollars, strengthening its position in immunology and signalling a major push into the emerging food allergy treatment market. The acquisition centres on...

read more
What is the Metabolic Reset Diet – The Science

What is the Metabolic Reset Diet – The Science

The science, the promise, and the pitfalls The idea of a “metabolic reset” has gained traction across wellness media, social platforms, and weight management programmes. The premise is appealing: that metabolism can be “retrained” or “rebooted” through short-term...

read more
Functional Gut Clinic Launches GI Clinical Trials Division

Functional Gut Clinic Launches GI Clinical Trials Division

The Functional Gut Clinic (FGC), the UK’s leading provider of specialist gastrointestinal (GI) diagnostics, today announced the launch of its dedicated GI Clinical Trials establishing the organisation as the country’s first boutique, end‑to‑end clinical research...

read more
Ergonomic Design Considerations in Health Tech

Ergonomic Design Considerations in Health Tech

Why comfort and fit are essential design considerations in medical devices In many industries, product design rarely accounts for the variability of user profiles, with a focus on the ‘average’ person.  Headphones or even glasses too often do not account for head size...

read more
EQT Targets Oxford Biomedica in Major Biotech Takeover Bid

EQT Targets Oxford Biomedica in Major Biotech Takeover Bid

Oxford Biomedica has officially confirmed it is in preliminary discussions with the Swedish private equity giant EQT regarding a potential cash takeover. The announcement follows significant market speculation and a sharp rise in the company’s share price on January...

read more

Featured Articles

DNA double helix beside a microscope, test tubes and a pipette over a petri dish, representing life science publishing

Life Science Publishing: Our First Year, and Where You Fit In

Almost a year ago, Life Science Daily News published its first articles with a simple belief. Specialist science deserves a specialist stage. Since then, that belief has grown into a global readership and an active community of contributors. This is the story of our...
FDA building exterior alongside pharmaceutical laboratory setting representing drug approval decisions

FDA Drug Approval Decisions

Last updated 28 October 2026. Covering target action dates from October 2026 to February 2027. October changed how this tracker has to be read. Six FDA drug approval decisions landed in the month, and four arrived ahead of target. One cleared roughly 12 weeks early,...
gloved hands holding a glowing blue sample vial (labelled LOT: 24-B1, SAMPLE: GENO-) with a lab researcher working in the background.

CRISPR Gene Editing 2026: Rare Diseases, Cancer and Autoimmune

CRISPR gene editing in 2026 is no longer a technology to watch. It is a technology delivering results. Across three distinct disease areas, rare inherited conditions, haematologic and solid cancers, and autoimmune disease, clinical programmes are accumulating...
Three GLP-1 drug pipeline injection pens and oral tablets beside a clinical trial efficacy chart on a clipboard

The GLP-1 Drug Pipeline: Every Candidate to Watch in 2026

The GLP-1 drug pipeline has become one of the most consequential and closely watched in modern pharmaceutical history. In 2026, the class of glucagon-like peptide-1 receptor agonists is no longer defined solely by Ozempic and Wegovy. A new generation of oral tablets,...
Sjögren's disease diagnosis: close-up of a dry, irritated eye with eye drops being applied

Anti-Ro52 vs Anti-Ro60: Advancing Sjögren’s Disease Diagnosis

Autoantibody testing is a central part of autoimmune disease diagnosis, including Sjögren’s disease (SjD). The American College of Rheumatology and European Alliance of Associations of Rheumatology (ACR/EULAR) classification criteria for SjD incorporate ocular and...

Further News

UK Boosts Clinical Trials With Faster, Agile Regulation

UK Boosts Clinical Trials With Faster, Agile Regulation

Press Release: Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation  The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments more...

read more
Five Ways AI Will Reshape Life Sciences in 2026

Five Ways AI Will Reshape Life Sciences in 2026

Why People, Process, and Purpose Matter Most Following a period of experimentation, life sciences is entering a pivotal new phase in AI adoption. The industry is shifting away from hype-driven pilots and toward proven, value-led applications that improve how therapies...

read more
Why Hormone Tracking will be a Key Health Trend for 2026

Why Hormone Tracking will be a Key Health Trend for 2026

Hormone health expert and bestselling author Dr Louise Newson explains why we'll all be tracking our hormones in 2026. The use of period tracking apps and menopause symptom tracker apps are at an all-time high. And it’s no wonder. These apps can be incredibly useful...

read more
OpenAI Accelerates Healthcare Strategy With ChatGPT Health

OpenAI Accelerates Healthcare Strategy With ChatGPT Health

OpenAI is making its most coordinated move into healthcare to date, positioning ChatGPT Health as a central interface for clinical, research, and operational use across the medical ecosystem. Rather than launching a single consumer-facing medical product, the company...

read more
The Lost World of Autism

The Lost World of Autism

Dhruv Shenai explores how females have been left behind in conversations on autism by discussing the history and lack of female representation within the field. Neuroscientist Gina Rippon has spent years challenging the male-centred bias in autism research. Her new...

read more

Further News

How Blood-Based Testing Could Close the Cancer Detection Gap

We have made real progress against cancer through better therapies, stronger treatments, and more precise diagnostics. Yet liver cancer, one of the fastest-rising causes of cancer-related death in the United States, remains a painful reminder that innovation does not...

Why Care Matching Still Struggles With Data, Location and AI

A family looking for home care may describe its situation in a few sentences. “My mother has dementia. She lives alone and needs someone there at night. She can still dress herself but sometimes forgets to eat. We need help soon.” A caregiver may describe her...

BMS, Lilly, Roche: The Pharma AI Supercomputer Race Heats Up

Bristol Myers Squibb announced on 20 July 2026 that it will deploy an NVIDIA DGX SuperPOD built on eight DGX Vera Rubin NVL72 systems, a move the company says will give it the most powerful and energy efficient single-owned NVIDIA infrastructure in the life sciences...

The False Economy of Returning to Manual PGD Processes

Across healthcare, financial pressure is forcing difficult decisions. Pharmacy teams are being asked to do more with less. Service expansion, dealing with NHS patients, workforce shortages remain acute, and every investment is being scrutinised. In this environment,...

Funding Pressures Push Researchers to Rethink Traditional Models

Australia's medical researchers have been handed a blunt new brief to simply do more with less. The newly published 10-year National Health and Medical Research Strategy from the Australian Government Department of Health, Disability and Ageing names a problem the...

IgA Nephropathy Drug Pipeline Reaches Six Approvals in Five Years

IgA nephropathy, the most common primary glomerulonephritis worldwide, has undergone a remarkable transformation in its treatment landscape. Once managed solely with supportive care and immunosuppression of uncertain benefit, the IgA nephropathy drug pipeline now...

Compliant on Paper, Exposed in Practice

A pharmaceutical manufacturer completes a technology transfer. The validation protocols have been approved. Training records are complete, documentation has been reviewed, and every required signature has been collected. The project passes its milestones and moves...

The One Leadership Skill That Turns the Ordinary Into the Extraordinary

As healthcare and life sciences organizations confront workforce shortages, regulatory pressures, rapid technological change, and increasing operational complexity, building a pipeline of extraordinary leaders has never been more important. Many of these organizations...

From Reactive Reviews to Predictive Regulatory Intelligence

Every regulatory professional has experienced the same moment. After months, and sometimes years, of preparing a Chemistry, Manufacturing, and Controls (CMC) submission, the application is finally submitted to a health authority. At that point, the questions begin....

The Patient as Healthcare’s Systems Integrator

Healthcare has undergone a remarkable digital transformation over the past two decades. Electronic health records, electronic prescribing, patient portals, telemedicine, artificial intelligence, and remote monitoring have fundamentally changed how healthcare is...

Why AI in Life Sciences Lives or Dies on its Data Foundations

AI has moved quickly in the life sciences making exciting breakthroughs and reframing how we think about healthcare. But beneath these breakthroughs, work is happening in places that rarely make headlines, data catalogues, validation plans, audit trails, integration...

Healthcare’s Claim-Denial Crisis Is an Administrative Epidemic

Healthcare has a second epidemic running alongside every clinical one, and it doesn't show up on a chart. It shows up in a fax queue. A claim gets denied, and somewhere in a hospital's business office, a trained professional begins a process that looks less like...

Want to Be Part of the Next Chapter in Life Sciences Media?

 

LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.

 

 

Don’t wait for the media to pick up your story. Be the media.

See More Articles

Want to Be Part of the Next Chapter in Life Sciences Media?

 

LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.

 

 

Don’t wait for the media to pick up your story. Be the media.